Collective Family Office LLC Reduces Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Collective Family Office LLC lessened its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 3.4% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 4,200 shares of the exchange traded fund’s stock after selling 150 shares during the period. Collective Family Office LLC’s holdings in SPDR S&P Biotech ETF were worth $349,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. Hillcrest Wealth Advisors NY LLC increased its position in SPDR S&P Biotech ETF by 0.6% during the first quarter. Hillcrest Wealth Advisors NY LLC now owns 21,368 shares of the exchange traded fund’s stock valued at $1,628,000 after acquiring an additional 125 shares during the last quarter. Legal Advantage Investments Inc. increased its position in SPDR S&P Biotech ETF by 0.6% during the first quarter. Legal Advantage Investments Inc. now owns 22,590 shares of the exchange traded fund’s stock valued at $1,722,000 after acquiring an additional 130 shares during the last quarter. FAS Wealth Partners Inc. increased its position in SPDR S&P Biotech ETF by 7.6% during the first quarter. FAS Wealth Partners Inc. now owns 1,889 shares of the exchange traded fund’s stock valued at $144,000 after acquiring an additional 134 shares during the last quarter. Commerce Bank increased its position in SPDR S&P Biotech ETF by 4.4% during the first quarter. Commerce Bank now owns 3,594 shares of the exchange traded fund’s stock valued at $274,000 after acquiring an additional 150 shares during the last quarter. Finally, Interactive Financial Advisors Inc. increased its position in SPDR S&P Biotech ETF by 1.8% during the first quarter. Interactive Financial Advisors Inc. now owns 8,628 shares of the exchange traded fund’s stock valued at $658,000 after acquiring an additional 156 shares during the last quarter.

SPDR S&P Biotech ETF Price Performance

SPDR S&P Biotech ETF stock traded down $1.02 during mid-day trading on Monday, reaching $76.09. 4,404,033 shares of the stock traded hands, compared to its average volume of 7,763,677. The stock has a market capitalization of $5.84 billion, a PE ratio of 11.47 and a beta of 0.97. SPDR S&P Biotech ETF has a 12-month low of $72.44 and a 12-month high of $92.60. The business’s 50-day moving average is $80.90 and its 200-day moving average is $81.67.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.